Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

AB&B BIO-TECH-B(02627.HK)

Event Tracking

Mar24

AB&B BIO-TECH-B FY2025 Annual Earnings Release on March 31, 2026 (BJT)

00:15

Mar4

Zhonghui Bio's mRNA Monkeypox Vaccine Receives FDA IND Approval

08:37

Feb26

ZHH Biology Expects Revenue Increase and Narrowed Net Loss for FY2025

10:03

Dec8

China Wisdom Biologics-B initiates Phase III clinical trial for freeze-dried human rabies vaccine

09:34

Sep4

Zhonghui Biopharma's Quadrivalent Influenza Vaccine Approved for All Age Groups

00:49

Aug28

AB&B BIO-TECH-B released FY2025 Q2 earnings on August 28, 2025 (BJT) with actual revenue of HKD 77.39 M and EPS of HKD -0.1039

15:00

Schedules & Filings

Schedules

Filings

Mar31

Earning Release(CST)

FY2025 Annual Earning Release

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 77.39 M, Net Income -37.43 M, EPS -0.1039

Aug11

IPO(CST)

Listing Price HKD 12.9

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

AB&B BIO-TECH-B(02627.HK)

AB&B BIO-TECH-B Stock Performance Chart